A Glycomics Approach Towards Understanding Alphavirus Induced Inflammatory Disease And Discovering Novel Therapeutic Targets
Funder
National Health and Medical Research Council
Funding Amount
$316,449.00
Summary
Alphaviruses are transmitted by mosquitoes and cause a variety of serious human infections. This project investigates how alphaviruses cause disease, with special focus on inflammatory musculoskeletal diseases. The expected outcomes are a better understanding of human viral diseases, with a view to improving prevention and treatment strategies to reduce the disease burden of alphaviruses and related viruses. The research strategy is a world-first, and the institute is an international leader in ....Alphaviruses are transmitted by mosquitoes and cause a variety of serious human infections. This project investigates how alphaviruses cause disease, with special focus on inflammatory musculoskeletal diseases. The expected outcomes are a better understanding of human viral diseases, with a view to improving prevention and treatment strategies to reduce the disease burden of alphaviruses and related viruses. The research strategy is a world-first, and the institute is an international leader in this area.Read moreRead less
How The Immune Response Can Affect Influenza Virus And Asthma
Funder
National Health and Medical Research Council
Funding Amount
$333,964.00
Summary
A strong immune response is essential for protection against viral infections. However, in some circumstances a strong immune response against viruses can actually further aggravate disease. In addition, an anti-viral immune response can trigger asthma attacks in allergic individuals. This research thus seeks to understand and therefore mitigate the potentially detrimental role of inflammation in influenza virus infections and asthma.
Combining Laboratory And Computational Approaches To Develop Reliable Low Cost HIV Prognostics
Funder
National Health and Medical Research Council
Funding Amount
$314,644.00
Summary
Certain anti-HIV drugs called "CCR5 antagonists" block HIV entry into immune cells. However, HIV drug-resistance can occur. Globally, patient access to CCR5 antagonists has been limited because the pre-treatment laboratory test required to determine HIV drug-resistant is expensive and time-consuming. My research will lead to development of computer programs that reliably, rapidly and cheaply determine HIV drug-resistance and thus greatly improve patient access to CCR5 antagonists worldwide.
A Novel RNA Repressor Element Regulates HIV-1 Replication
Funder
National Health and Medical Research Council
Funding Amount
$341,453.00
Summary
HIV-1 causes acquired immunodeficiency syndrome, with up to 40 million infected people and 5 million infected annually. The spatio-temporal regulation of HIV-1 reverse transcription has recently been recognised as a possible new drug target. Our research has revealed a novel repressor of reverse transcripiton (RRT). The RRT plays a major role in regulating the spatio-temporal regulation of reverse transcripiton. Targetting the RRT function would be a novel means to combat HIV-1 infection.